Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS
Public ClinicalTrials.gov record NCT02190149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02190149
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Baxalta now part of Shire
- Industry
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- ADVATE (Antihemophilic Factor [Recombinant]) Biological
- RIXUBIS (Coagulation Factor IX [Recombinant]) Biological
Biological
Eligibility (public fields only)
- Age range
- 13 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2014
- Primary completion
- Mar 28, 2016
- Completion
- Mar 28, 2016
- Last update posted
- Mar 16, 2021
2014 – 2016
United States locations
- U.S. sites
- 17
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center | Los Angeles | California | 90007 | — |
| Rady Childrens Hospital | San Diego | California | 92123 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Bleeding and Clotting Disorders Institute | Peoria | Illinois | 61615 | — |
| University of Kentucky Medical Center | Lexington | Kentucky | 40504 | — |
| Johns Hopkins University School Of Medicine | Baltimore | Maryland | 21205 | — |
| Childrens Hospital of Michigan | Detroit | Michigan | 48201 | — |
| Michigan State University | East Lansing | Michigan | 48823 | — |
| Munson Medical Center | Traverse City | Michigan | 49684 | — |
| Children's Mercy Hospitals & Clinics | Kansas City | Missouri | 64108 | — |
| North Shore/Long Island Jewish PRIME | Great Neck | New York | 11021 | — |
| The Presbyterian Hospital | Charlotte | North Carolina | 28210 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| The Vanderbilt Clinic | Nashville | Tennessee | 37232 | — |
| The University of Texas MD Anderson | Harlingen | Texas | 78550 | — |
| Puget Sound Blood Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02190149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2021 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02190149 live on ClinicalTrials.gov.